The Difference of Oropharyngeal Leak Pressure and Sealing Pressure Between New Supraglottic Airway Devices (SGA)

November 24, 2020 updated by: National Taiwan University Hospital
The difference of oropharyngeal leak pressure and sealing pressure between new supraglottic airway devices.

Study Overview

Status

Unknown

Detailed Description

In this clinical study, investigators want to discuss the issue that oropharyngeal leak pressure and sealing condition with different SGA including air-Q、i-gel、LMA-supreme、AMBU auragain 、ProSeal LMA and other new SGAs.

In the perioperative period, investigators documented respiratory function data including oropharyngeal leak pressure and peak airway pressure in these randomly selected SGA. Oropharyngeal leak pressure was measured by closing the expiratory valve of the circle system at fixed O2 flow 3L/min and noting the airway pressure at which the dial on a calibrated aneroid manometer reached equilibrium.

investigators wanted to compared the respiratory function between air-Q、i-gel、LMA-supreme、AMBU auragain、ProSeal LMA and other new SGAs during surgery and postoperative care unit.

Study Type

Observational

Enrollment (Anticipated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

All general anesthesia patients who use SGA.

Description

Inclusion criteria:

  1. 20-80 years old.
  2. ASA physical status I or II .
  3. Without major organ dysfunction like heart, liver, brain, lung, kidney function failure.

Exclusion criteria:

  1. BMI> 35 kg/m2.
  2. Risk of aspiration(NPO clear water> 2 hours, solid foods > 8 hours).
  3. Difficult airway like head and neck tumor or airway tumor.
  4. Limited mouth opening (<2cm).
  5. major organ dysfunction including heart, liver, brain, lung, kidney function failure.
  6. Major surgery including open heart surgery, laparotomy general surgery, open chest surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
SGA type 1
Observe the function of SGA type 1
SGA type 2
Observe the function of SGA type 2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oropharyngeal leak pressures
Time Frame: 10 minutes
oropharyngeal leak pressure units ( cmH2O )
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1. The participant's head and neck position 2. The number of attempts required for SGA insertion 3. Ease of gastric tube placement 4. The ventilation score
Time Frame: 180 minutes
  1. The participant's head and neck position (neutral/extension/flexion/rotation)
  2. The number of attempts required for SGA insertion (1/2/3/tracheal intubation)
  3. Ease of gastric tube placement (success/failure/Leak)
  4. The ventilation score was scored from 0 to 3 based on three criteria:

(1) No leakage with an airway pressure of > 15 cm H2O (2) Bilateral chest excursions with a peak inspiratory pressure of > 20 cm H2O (3) A Square Wave Capnography with each item scoring 0 or 1 point. Thus, if all three criteria were satisfied, the ventilation score was 3.

180 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Liu Chih Min, visiting staff

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 25, 2020

Primary Completion (Anticipated)

July 30, 2021

Study Completion (Anticipated)

July 30, 2021

Study Registration Dates

First Submitted

October 7, 2020

First Submitted That Met QC Criteria

November 24, 2020

First Posted (Actual)

December 2, 2020

Study Record Updates

Last Update Posted (Actual)

December 2, 2020

Last Update Submitted That Met QC Criteria

November 24, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 201907019RINC

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oropharyngeal Leak Pressure

3
Subscribe